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1. Introduction 
Gastric cancer is the second most frequent cause of cancer-related mortality in the world, 
and is the most common malignancy of the gastrointestinal tract in East Asian populations 
(Parkin et al., 1997; Parkin et al. 1999). Helicobacter pylori (H. pylori) is an established risk 
factor for developing gastric cancer and its precancerous lesions, which was evidenced by 
numerous epidemiological studies (Hamilton & Aaltonen, 2000; Tsuji et al., 2006). More than 
50% of the world’s population is estimated to be infected with this bacterium (Danesh, 
1999). It is demonstrated that the risk of the subjects with H. pylori infection is from 2- to 6-
fold (Eslick et al., 1999). In addition, some trials on H. pylori eradication revealed that cure of 
its infection reduces the gastric cancer development in high-risk populations (Fukase et al., 
2008; Wong et al., 2004). 
2. Genetic factors involved in the genesis of Helicobacter pylori-induced 
gastric cancer 
Accumulated evidence has shown that there are three steps in gastric carcinogenesis: H. 
pylori infection, development of gastric precancerous lesions, and gastric carcinogenesis 
(Hamajima et al., 2006). For each of these three steps there are specific genetic traits that 
influence the process interacting with lifestyle factors (Figure 1).  
2.1 Genetic traits for the persistence of Helicobacter pylori infection 
H. pylori is transmitted from person to person through the oral-oral or fecal-oral route 
mainly during the childhood. 
Such factors as will directly affect the H. pylori transmission like sewage systems are also 
essential determinants of the infection. Although there is limited supporting biological 
evidence, some lifestyle factors such as salty food intake, low fruits intake, or smoking 
might play a role in persistent H. pylori infection. 
Genetic traits could influence persistent H. pylori infection interacting with lifestyle factors. 
2.1.1 Genetic polymorphisms of the molecules associated with gastric acid secretion 
Gastric acid is secreted from parietal cells, and regulated by histamine, gastrin, and acetyl 
choline. It is known that IL-1ǃ and TNF-ǂ, proinflammatory cytokines, inhibit gastric acid 
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Fig. 1. Steps in Helicobacter pylori-induced gastric cancer. 
secretion (Beales et al., 1998), and H. pylori infected patients showed a marked increase in IL-
1ǃ mRNA in mucosa (Wang et al., 1999). A recent study demonstrated that IL-1ǃ decreased 
gastrin level (Chakravorty et al., 2009), elucidating the mechanism of the acid secretion 
reduction due to H. pylori infection. IL-1ǃ induces TNF-ǂ, and vice versa. Although IL-1ǃ 
and TNF-ǂ have several roles, polymorphisms connected to both molecules are classified as 
one group in this chapter (Table 1).  
 
 
Fig. 2. Signal pathways from Helicobacter pylori infection to pro-inflammatory gene 
expression. 
IL-1A 
IL-1A making a cluster in chromosome 2q14 with IL-1B and IL-1RN has two single 
nucleotide polymorphisms (SNPs) of C-889T and G4845T, as well as a 46-bp variable 
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number of tandem repeats (VNTR) polymorphism (Bailly et al., 1993). It was reported that 
the combination IL-1A -889TT and IL-1B -511T (-511TT or -511TC) was related to high 
plasma levels of IL-1ǃ (Hullkonen et al., 2000). The association with H. pylori infection was 
examined only for a Japanese population (Hamajima et al., 2001), providing no association 
of IL-1A C-889T (Table 1). In the study, the association with 46-bp VNTR polymorphism was 
not examined, because the polymorphism was not found among Japanese (Hamajima et al., 
2002a). Polymorphism G4845T was reported to be linked with C-889T (Armitage et al., 
2000). 
IL-1B 
Three polymorphisms of IL-1B T-511C, C-31T, and C3954T located in chromosome 2q14, 
have been studied for many diseases. It is known that -511T and -511C are tightly linked 
with -31C and -31T, respectively (Hamajima et al., 2001a). An electrophoretic mobility-shift 
assay demonstrated that C-31T was a functional polymorphism (El-Omar et al., 2000), while 
C3954T is unlikely to be functional.  
We conducted four studies for Japanese and Japanese Brazilians, all of which showed a 
similar result, that those with -31TT had a higher risk of H. pylori seropositivity (Hamajima 
et al., 2001a; Hamajima et al., 2002b; Uno et al., 2002). The risk elevation was marked for 
smokers except one study (Hamajima et al., 2002b). Since cigarette smoke includes about 
4,000 chemicals, many genes may be upregulated or downregulated. A study on C-31T in 
Brazil showed a higher seropositive rate for those with -31TT genotype, though not 
significant (Queiroz et al., 2009). Concerning T-511C polymorphism, no associations were 
found among Japanese (Kato et al., 2001) and Koreans (Kim et al., 2006), while a Chinese 
study reported a significant association with -511T allele (-511TT + -511TC) (Liou, 2007), 
which was linked to -31C allele.  
IL-1RI 
There are two receptors for IL-1ǃ; IL-1RI and IL-1RII. The former transduces the signal, but 
the latter does not. IL-1RI in 2q12 has reportedly four polymorphisms; C-116T (RFLP-A), C-
90T, T49C, and RFLP-B at an unknown site (Bergholdt et al., 1995). There were no reports on 
the association between these polymorphisms and H. pylori seropositivity, except our study 
for C-116T indicating no association (Hamajima et al., 2003a). 
IL-1RN 
IL-1RN has an 86-bp VNTR polymorphism. Among 241 Japanese, the allele frequency was 
4.1% for 2 repeat allele, 0.2% for 3 repeat allele, 94.6% for 4 repeat allele, and 1.0% for 5 
repeat allele (Hamajima et al., 2001a). No significant differences in H. pylori soropositivity 
among different genotypes of IL-1RN 86-bp VNTR were observed for Japanese, Koreans, 
and Chinese (Hamajima et al., 2001a; Kim et al., 2006; Liou et al., 2007). Since the minor 
alleles are rare for the three ethnic groups, statistical power of these studies was not enough.  
TNF-A 
TNF-A and TNF-B genes are located between HLA-B and HLA-DR on 6p21.3. In the 
promoter area of TNF-A, G-238A, G-244A, G-308A, C-857T, C-863A, and T-1031C were 
reported (Kamizono et al., 2000; Yamaguchi et al., 2001). Among East Asians, -238A, -244A 
and -308A alleles were rare (2.0%, 0.0% and 1.7%, respectively in Japanese (Kamizono et al., 
2000; Yamaguchi et al., 2001)), and C-863A was tightly linked with T-1031C (Higuchi et al., 
1998). The functions of these alleles were controversial, but -308A was regarded as a high 
expression allele (D’Alfonso et al., 1994). 
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Subjects (Reference)          aOR or HP% 
IL-1A C-889T CC  CT/TT 
241 Japanese (Hamajima, 2001a) 62% (n=201) 68% (n=39) / (n=1) 
IL-1B C-31T   CC  CT  TT 
241 Japanese (Hamajima, 2001a) 1   (n=42)  2.32* (n=133)  2.46* (n=66) 
55 smokers 1   (n=16)  6.18* (n=27)  22.9* (n=12) 
465 Japanese (Uno, 2002) 1   (n=116) 0.97 (n=183) 1.73* (n=163)  
  80 ever smokers 1    (n=23) 1.68 (n=34) 5.29* (n=22)  
547 Japanese (Hamajima, 2002a) 1    (n=116) 1.32 (n=237) 1.35   (n=178) 
127 smokers 1    (n=23) 1.12 (n=60) 1.01   (n=41) 
963 Jpn. Brazil. (Uno, 2002) 1    (n=226) 1.30 (n=432) 1.45* (n=289) 
124 smokers 1    (n=ND) 2.45 (n=ND) 3.49* (n=ND) 
541 Brazil. (Queiroz, 2009) 64% (n=112) 71% (n=265) 67%   (n=164) 
IL-1B T-511C TT   TC  CC 
499 Japanese (Kato, 2001) 52%  (n=113) 54% (n=243) 53%   (n=143) 
474 Koreans (Kim, 2006) 86%  (n=131)  86% (n=259)  88%   (n=84) 
663 Chinese (Liou, 2007) 67%  (n=148) 64% (n=343) 55%*  (n=172) 
IL-1RI C-116T CC  CT  TT 
241 Japanese (Hamajima, 2003a) 65%  (n=93) 58% (n=114) 72%  (n=32) 
IL-1RN VNTR 4rpt/4rpt 2rpt  Others 
241 Japanese (Hamajima, 2001a) 62%  (n=217) -  67%  (n=24) 
474 Koreans (Kim, 2006) -  80%  (n=60) 87%  (n=414) 
663 Chinese (Liou, 2007) -  66% (n=53) 61%  (n=540) 
540 Brazil. (Queiroz, 2009) 67%  (n=378) 70%  (n=162) - 
TNF-A T-1031C TT   TC  CC 
1,374 Japanese (Hamajima, 2003a) 1    (n=952) 0.92  (n=385) 0.43* (n=34) 
963 Jpn. Brazil. (Atsuta, 2006) 1.18  (n=648) 0.96  (n=269) 1  (n=31) 
TNF-A C-857T CC CT TT 
1,374 Japanese (Hamajima, 2003a) 1  (n=931) 1.06  (n=373) 1.69  (n=42) 
963 Jpn. Brazil. (Atsuta, 2006) 1  (n=613) 1.17  (n=301) 1.21  (n=36) 
TNF-A -1031 & -857 CC&CC    TT&CC      TC&CT      TT&TT 
1,374 Japanese (Hamajima, 2003a) 1(n=34)  2.37*(n=595)  2.84*(n=76)  3.63*(n=42) 
963 Jpn. Brazil. (Atsuta, 2006) 1(n=30)  1.08 (n=377)  1.03 (n=67)   1.27 (n=35) 
253 ever smokers 1(n=11)  2.01 (n=102)  1.76 (17)      2.30 (n=5) 
TNF-A G-308A GG  GA  AA 
393 Germans (Kunstmann, 1999) 52%  (n=277) 56%  (n=89) 56% (n=18) 
792 Italians (Zambon, 2005) 54%  (n=ND) 61%*  (n=ND) -    (n=ND) 
474 Koreans (Kim, 2006) 86%  (n=400) 89% for GA(n=59)/AA(n=2) 
539 Brazil. (Queiroz, 2009) 70%  (n=403) 66%  (n=123) 46%  (n=13) 
TNF-B A252G AA AG GG 
1,374 Japanese (Hamajima, 2003a) 1   (n=501) 1.05  (n=656) 1.05  (n=204) 
*: statistically significant (p<0.05), Jpn. Brazil.: Japanese Brazilians, and ND: not described.  
Table 1. Genetic polymorphis of molekuls potentially related with gastric acid secretion, 
reported on the associations with Helicobacter pyloriinfections: sex-age-ajusted odd ratio 
(aOR) or seropositive percentage (HP%) 
www.intechopen.com
 Genetic Factors Involved in the Genesis of Helicobacter Pylori-Induced Gastric Cancer 
 
243 
Among the studies reported on the TNF-A polymorphisms (Queiroz et al., 2009; Kim et al., 
2006; Hamajima et al., 2003b; Atsuta et al., 2006; Kunsmann et al, 1999; Zambon et al., 2005), 
significant associations were found for T-1031C and for the combination of T-1031C and A-
857T among 1,374 Japanese (Hamajima et al., 2003), as well as for G-308A among 792 Italians 
(Zambon et al., 2005). If -1031T and -857T are the high expression alleles, the findings of the 
studies on TNF-A seemed rather consistent to indicate that high TNF-ǂ expression favors 
persistent H. pylori infection. 
TNF-B 
TNF-B A252G, whose G allele is strongly linked with TNF-A -857C allele in Japanese 
(Hamajima et al., 2003b), was not associated with seropositivity, as shown in Table 1. 
Another polymorphism, TNF-B Thr26Asn, was found to link completely with A252G. 
2.1.2 Genetic polymorphisms of molecules associated with innate immune responses 
Innate immune responses have not completely been understood. The polymorphisms of the 
molecules possibly involved in the innate immune responses are selected in this section 
(Table 2). 
CD14 
CD14, located in chromosome 5q31.1, has a polymorphism C-159T. Serum soluble CD14 was 
reported to be significantly higher in those with -159TT (n=42, median=4.5μg/ml) than in 
those with -159CC (n=67, median=4.1μg/ml) (Baldini et al., 1999). Although the 
polymorphism seemed functional, no association was found with H. pylori seropositivity 
(Hamajima et al., 2003a). 
CXCR2 
CXCR2 in 2q35 was reported to have three polymophisms; C785T causing a silent codon 
change in leucine, and T1208C and G1440A in the 3’ untranslated region of exon 3 (Renzoni 
et al., 2000). These polymorphisms are tightly linked, forming a haplotype with 785C, 1208T, 
and 1440G. Accordingly, any polymorphism of the three may be used for a pilot association 
study on disease risk. No significant difference was observed in the seropositive rate among 
the three genotypes of C785T in Japan (Hamajima et al., 2003a). 
IL-2 
T-330G of IL-2 gene on chromosome 4q26-27 was reported to be a functional polymorphism; 
the production was higher in -330GG genotype than in TT genotype (Williams et al., 1988; 
Hoffmann et al., 2001). The -330TT was at a higher risk of gastric atrophy (Togawa et al., 
2005) and less frequent among Asians (38% out of 29 individuals) than among Caucasians 
(51% out of 199 individuals) (Hoffmann et al., 2002). While the polymorphism was not 
associated with H. pylori seropositivity among Japanese (Togawa et al., 2005), -330TT 
genotype was significantly associated with the seropositivity relative to -330C allele 
(CC+CT) among Brazilians (Queiroz et al., 2009).  
IL-4 
IL-4 C-33T on chromosome 5q31.1 was reported to be functional; IL-4 protein production 
was higher in -33TT genotype than in -33CC genotype (Nakashima et al., 2002). Our dataset 
showed no association with H. pylori seropositivity in Japanese (Togawa et al., 2005). 
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IL-8 
IL-8 located in chromosome 4q12-q21 was reported to have nine polymorphisms (four in 5’ 
upstream regions, four at introns, and one in 3’ downstream region). Among Europeans, 
two haplotypes, one with -1722delT, -251A, 396G, 781T, 1633T, and 2767T termed 
delTAGTTT in the order of those polymorphisms, and the other with delTTTCCA, are 
dominant with frequencies of 0.41 and 0.52, respectively. The haplotypes are more diverse 
among Africans; delTAGCCA (frequency 0.36), delTATCCA (0.19), insTATCCA (0.18), and 
delTTTCCA (0.10), respectively (Hull et al., 2001), but the genotyping of T-251A and T396G 
is sufficient for classifying the haplotypes even among Africans. Among Japanese, there was 
a strong linkage between the two polymorphisms; 396TT was found in 90.0% of 110 
individuals with -251TT, 396TG in 90.5% of 95 individuals with -251TA, and 396GG in 100% 
of 22 individuals with -251AA (Hamajima et al., 2003c), indicating that T-251A is a good 
marker for Japanese. 
Although a study on IL-8 expression found that the A allele had a higher expression than 
the T allele (Hull et al., 2001). Plasma IL-8 levels was found to be higher in A allele carriers 
among those with H. pylori seronegative, but lower among the seropositives without gastric 
atrophy (Naito et al., 2010). Although no significant association was found with the 
seropositivity, the point estimate of the adjusted odds ratio was less than unity for the A 
allele carriers (Hamajima et al., 2003c). 
IL-10 
IL-10 G-1082A and T-819C polymorphisms were reported to influence the expression of IL-
10 mapped on 1q31-32; -1082A and -819T are high expression alleles (Turner et al., 1997; 
Helminen et al., 2001). There is a large difference in -1082G allele frequency among different 
regions; 0.51 in Belfast, 0.52 in Glasgow, and 0.47 in Strasbourg (Donger et al., 2001), but 0.04 
among Japanese(Ito et al., 2000). We found that there was no significant association between 
T-819C and H. pylori seropositivity. 
As mentioned, a high level of IL-10 and a lower level of IL-8 create favorable conditions for 
prolonging the H. pylori infection in human gastric mucosa. Accordingly, the combination of 
IL-8 -251TT (the low expression genotype) and IL-10 -819TT (the high expression genotype) 
was expected to be favorable for persistent H. pylori infection. Among three studies, one 
study demonstrated that the other combinations were at a significantly lower risk of the 
persistent infection (Hamajima et al., 2003c), but another study was opposite (Hamajima et 
al., 2003a). When smokers were selected, the genotype combinations other than IL-8 -251TT 
and IL-10 -819TT were at a lower risk in the three studies, though not significant for two 
studies (Table 2). 
IL-13 
IL-13 is a Th2 cytokine, whose gene is located in 5q31. Closely linked polymorphisms, A-
1512C, C-1111T, and Arg130Gln, have been examined for disease risk (Beghe et al., 2009). 
Although the association between gastric atrophy development and C-1111T was observed 
(Togawa et al., 2005), there was no association with the seropositivity. 
MPO 
Myeloperoxidase (MPO) is a lysosomal enzyme in polymorphonuclear leukocytes and 
monocytes. It produces hypochlorous acid to kill a wide range of organisms. While 
mutations, Arg569Trp, Val173Cys, or Met251Thr of MPO located in 17q23.1 cause fatal 
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diseases such as chronic granulomatous disease due to severe enzyme activity deficiency 
(Nauseef et al., 1994), MPO G-463A exhibits less influential, but the transcription level of A 
allele was reported to be one twenty-fifth of G allele (Piedrafita et al., 1996). Two studies 
showed the A allele carriers were at a lower risk of the seropositivity, though not significant 
(Hamajima et al, 2001b; Katsuda et al, 2003). Intuitively, low enzyme activity seemed to 
provide a favorable situation, but the results were opposite. 
NF-KB2 
NF-KB2 encoding NF-κB2 (p100) has a Ins/Del polymorphism at -10G (or 1867GG/G), as 
well as two polymorphisms with a rare minor allele (Shinohara et al., 2001). Although the 
function of Ins/Del -10G has not been demonstrated, no association was found with H. 
pylori seropositivity (Hamajima et al., 2003a). 
NOS2 
Nitric oxide synthase (NOS) was three isozymes; neuronal constitutive NOS (nNOS) 
encoded by NOS1, inducible NOS (iNOS) encoded by NOS2, and endothelial constitutive 
NOS (enNOS) encoded by NOS3. There were several polymorphisms reported for NOS2 in 
chromosome 17cen-q11.2, such as C-1173T, G-954C, (TAAA)n, and (CCTTT)n. A C150T 
(Ser608Leu) polymorphism at exon 16 was reported to have an association with type 1 
diabetes (Johannsen et al., 2001), but the association with H. pylori was not observed among 
Japanese (Goto et al., 2006a). There were no studies with the other polymorphisms of NOS2. 
NQO1 
NQO1 is an obligate two-electron reductase, whose gene is located in chromosome 16q22 
(Ross et al., 2000). The gene has a functional polymorphism C609T (Pro187Ser); the T allele 
has no enzyme activity (Siegel et al., 1999). The CC genotype was found that to favor 
persistent H. pylori infection among Japanese (Goto et al., 2005). 
ODC 
ODC in chromosome 2p25, encoding ornitine decarboxylase, has a functional polymorphism 
G317A in intron 1; the expression was higher in the A allele than in the G allele (Guo et al., 
2000). Aspirin chemoprevention of colorectal adenoma recurrence was reported to be more 
effective among those with 317AA than those with the other genotypes. The 317AA 
genotype was 5-7% in Europe and the United States (Hubner et al., 2008), while it was 36% 
in Japan (Goto et al., 2007). The association with H. pylori seropositivity was not observed 
among Japanese (Goto et al., 2007).   
TLR2 
Arg677Trp, Arg753Gln, and Ins/Del at -196 to -174 were reported as polymorphisms of 
TLR2 on chromosome 4q32 (Queiroz et al., 2009; Tahara et al., 2007). Although the minor 
allele was rare, the association with Arg753Gln was examined among Brazilians. They 
found no association with the polymorphism (Queiroz et al., 2009). 
TLR4 
In TLR4 on chromosome 9q32-33, two polymorphisms, Asp299Gly and Thr399Ile, have been 
reported. The 299Gly/399Ile allele is less sensitive to LSP than 299Asp/399Thr allele, 
resulting in lower NF-κB activity (Arbour et al., 2000). The LPS-hyposensitive allele was 
found to be 5.9% among 879 blood donors in England (Read et al., 2001), but not found 
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py g j ( ) p p g ( )
Subjects [Reference]          aOR or HP% 
CD14 T-159C TT  TC  CC 
1,374 Japanese (Hamajima, 2003a) 1 (n=413) 0.94  (n=678) 1.16  (n=413) 
CXCR2 C785T   CC  CT  TT 
241 Japanese (Hamajima, 2003a) 65%  (n=110) 63%  (n=100) 56%  (n=25) 
IL-2 T-330G GG  GT  TT 
  454 Japanese (Togawa, 2005) 1    (n=45) 1.10  (n=196) 1.15  (n=202) 
541 Brazil. (Queiroz, 2009) 70%  (n=27) 63% (n=221) 72%*  (n=293) 
IL-4 C-33T CC  CT  TT 
  454 Japanese (Togawa, 2005) 1 (n=42) 1.43  (n=183) 1.25  (n=227) 
IL-8 T-251A TT   TA  AA 
454 Japanese (Hamajima, 2003c) 1 (n=234) 0.86 (n=177) 0.70 (n=37) 
IL-10 T-819C TT  TC  CC 
454 Japanese (Hamajima, 2003c) 1 (n=220) 0.67 (n=177) 0.82 (n=37) 
IL-8 & IL-10 TT&TT Others 
454 Japanese (Hamajima, 2003c) 1    (n=115) 0.62*  (n=327) 
  65 smokers 1 (n=ND) 0.13*  (n=ND) 
241 Japanese (Hamajima, 2003a) 1    (n=57) 1.04  (n=178) 
  55 smokers 1    (n=ND) 0.45  (n=ND) 
679 Japanese (Hamajima, 2003a) 1    (n=164) 1.49*  (n=507) 
158 smokers 1    (n=ND) 0.89  (n=ND) 
IL-13 C-1111T CC  CT  TT 
  454 Japanese (Togawa, 2005) 1   (n=310) 0.73  (n=127) 1.09  (n=11) 
MPO G-463A GG   GA/AA 
241 Japanese (Hamajima, 2001b) 1    (n=192) 0.69  (n=47)/(n=2) 
454 Japanese (Katsuda, 2003) 1    (n=354) 0.84  (n=77)/(n=6) 
NF-KB2 -10G InsIns InsDel DelDel 
1,374 Japanese (Hamajima, 2003a) 1    (n=513) 1.03  (n=648) 1.15  (n=199) 
NOS2 C150T (Ser608Leu) CC  CT  TT  
454 Japanese (Goto, 2006a) No association 
NQO1 C609T (Pro187Ser) TT   TC  CC 
241 Japanese (Goto, 2005a) 1 (n=48) 1.13  (n=107) 2.42*  (n=86) 
454 Japanese (Goto, 2005a) 1 (n=83) 1.57  (n=210) 1.70  (n=153) 
ODC A317G AA   AG  GG 
465 Japanese (Goto, 2007) 1    (n=167) 1.09  (n=229) 1.02  (n=69) 
TLR2 Arg753Gln ArgArg ArgGln GlnGln 
541 Brazil. (Queiroz, 2009) 68%  (n=531) 70% (n=10) -    (n=0) 
TLR4 Asp299Gly AspAsp AspGly GlyGly 
541 Brazil. (Queiroz, 2009) 68% (n=490) 71% (n=51) -    (n=0) 
TLR4 G3725C GG  GC  CC 
1,592 Japanese (Hishida, 2009a) 1 (n=827) 0.95  (n=474) 0.72  (n=90)  
TLR5 Arg392Ter ArgArg ArgTer TerTer 
541 Brazil. (Queiroz, 2009) 68% (n=504) 71% (n=34) 67% (n=3) 
* Statistically significant (p<0.05), Jpn. Brazil.: Japanese Brazilians, Brazil.: Brazilians  
Table 2. Genetic polymorphisms of molecules potentially involved in innate responses, 
reported on the associations with Helicobacter pylori infection: sex-age-adjusted odds ratio 
(aOR) or seropositive percentage (HP%) 
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among 275 Japanese (Tahara et al., 2007). For Japanese, G3725C in 3’UTR was reported to 
have an association with periodontitis. We found that the polymorphism had an association 
with severe gastric atrophy, but did not with persistent H. pylori infection (Hishida et al., 
2009a). 
TLR5 
A polymorphism TLR5 Arg392Ter on chromosome 1q41-42 was examined for the 
association among Brazilans (Queiroz et al., 2009). There was no significant association in 
the study. 
2.1.3 Genetic polymorphisms of molecules associated with adhesion to epithelial 
cells 
BabA of H. pylori binds of H type I and Lewis b antigen carbohydrate structure on human 
epithelial cells. H type I is synthesized from Type I precursor with secretor enzyme encoded 
by FUT2, and further metabolized to Lewis b with Lewis enzyme encoded by FUT3. Both 
enzymes are fucosyltransferase. 
FUT2 (secretor gene) 
Although many polymorphisms were reported, main alleles of FUT2 located in 19q13.3 are 
Se1 (357C, 385A, 571C, 628C), Se2 (357T, 385A, 571C, 628C), sej (357T, 385T, 571C, 628C), se3 
(357C, 385A, 571T, 628C), se4 (357C, 385A, 571C, 628T), and se5 (combined with a 
pseudogene). Se1 and Se2 exhibit full enzyme activity, while sej shows very low activity, 
and se3, se4, and se5 reveal no activity. Accordingly, Se1 and Se2 are denoted by Se, and the 
others by se. Among Caucasians, se3 and se4 are common se alleles, whereas in East Asians 
se5 and sej are main se alleles (Narimatsu et al., 1998). Since those with sese genotype cannot 
synthesize H type I nor Lewis b, they were expected to have the lower seropositive rate. Our 
first study fitted the expectation (Ikehara et al., 2001), but it was not confirmed in the second 
and third datasets (Hamajima et al., 2002b). Those with sese genotype was reported to be 
resistance for Norwalk virus infection (Lindesmith L et al., 2003). 
 
Subjects [Reference]               aOR 
FUT2  SeSe  Sese  sese 
241 Japanese (Ikehara, 2001) 1  (n=61) 0.79  (n=127) 0.35*  (n=51) 
679 Japanese (Hamajima, 2002c) 1  (n=170) 1.51* (n=328) 1.50  (n=181) 
464 Japanese (Hamajima, 2002c) 1  (n=139) 1.57  (n=218) 1.29  (n=107) 
FUT3 LeLe  Lele  lele 
241 Japanese (Hamajima, 2002c) 1  (n=124) 1.95* (n=98) 2.80  (n=17) 
679 Japanese (Hamajima, 2002c) 1  (n=353) 0.98  (n=251) 1.31  (n=59) 
424 Japanese (Hamajima, 2002c) 1  (n=235) 1.06  (n=155) 1.40  (n=33) 
* Statistically significant (p<0.05) 
 
Table 3. Genetic polymorphisms of other miscellaneous molecules, reported on the 
associations with Helicobacter pylori infection: sex-age-adjusted odds ratio (aOR) or 
seropositive percentage (HP%) 
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FUT3 (Lewis gene) 
FUT3 has three polymorphisms; T59G, G508A, and T1067A. An Le allele is defined as one 
with 59T, 508G, and 1067T, an le1 allele with 59G, 508A, and 1067T, an le2 allele with 59G, 
508G, and 1067A, and an le3 allele with 59G, 508G, and 1067T. The le1 and le2, denoted by le, 
lack enzyme activity. Since le3 shows almost full enzyme activity, it is grouped into Le 
(Narimatsu et al., 1998). The LeLe genotype, which may disturb the synthesis of H type I by 
FUT2 through sharing the same substrate (type I precursor), showed the lower 
seropositivity in the first dataset, while the finding was not reproduced by the second and 
third datasets (Hamajima et al., 2002b) (Table 3).  
2.2 Genetic predisposition to Helicobacter pylori-induced gastric precancerous 
lesions 
The presence of gastric lesions outside the tumor was recognized as gastric precancerous 
lesions in gastrectomy specimens or biopsies taken by flexible gastroscopes, which lead to 
the development of a model of gastric carcinogenesis generally accepted. Long-term follow-
up of cohorts in high-risk populations has documented the dynamics of gastric 
precancerous process. Severe gastric atrophy, corpus-predominant gastritis, intestinal 
metaplasia and dysplasia are well-recognized predominant predispositions to gastric cancer 
(Correa P, 1988; Uemura et al., 2001). 
There seems to be a considerable variation in the extent of these gastric damages due to H. 
pylori infection from one subject to another, suggesting that genetic factors are playing 
important roles in the long-term outcome of H. pylori infection. 
Although biological mechanisms underlying the genesis of gastric precancerous conditions 
remain largely unknown, both direct effects by the virulence factors of H. pylori, such as 
cytotoxin-associated gene A (CagA), and indirect effects derived from pro-inflammatory 
immune response by the host seem to be involved (Takahashi et al., 2007) (Table 4). 
2.2.1 Cag pathogenicity island-related genes and their polymorphisms 
The main effects of H. pylori virulence factors on the development of gastric precancerous 
lesions may be represented by the CagA. CagA is a 120 to 145-kDa H. pylori protein 
encoded by the cagA gene, which is localized at one end of the cag pathogenicity island 
(cagPAI), a 40-kb DNA segment considered to be horizontally transfected to the H. pylori 
genome (Censini et al., 1996; Akopyants et al., 1998). CagA is delivered from H. pylori 
bacterium into host cell cytoplasms through the type IV secretion system and undergoes 
tyrosine phosphorylation. In the injected gastric epithelial cells, CagA induces cellular 
spreading and elongation called the ‘hummingbird phenotype’, which is thought to play 
important roles in H. pylori-induced gastric carcinogenesis.  In this CagA-dependent 
morphologic transformation of gastric epithelial cells, a key molecule SHP-2 (src 
homology 2 domain-containing protein tyrosine phosphatase-2) is required. Binding of 
tyrosine phosphorylated CagA to the SH2 domains of SHP-2 causes a conformational 
change in SHP-2 itself which leads to the aberrant activation of SHP-2 phosphatase. SHP-2 
plays a major role in intracellular signaling provoked by various growth factors, 
hormones or cytokines, and is widely expressed in both embryonic and adult tissues 
(Higashi et al., 2002). SHP-2 is required for full activation of the Ras-MAP kinase cascade 
in response to growth factor-receptor interaction and plays an important role in cell 
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morphogenesis as well as cell mortility (Higashi et al., 2002), which might partly explain 
the mechanism for the formation of hummingbird phenotype. 
Meanwhile, CagA is shown to disrupt the tight junctions and causes loss of epithelial apical-
basolateral polarity through the specific interaction of CagA with partitioning-defective-1 
(PAR1)/ microtubule affinity-regulating kinase-2 (MARK2) (Sadaat et al., 2007) (Figure 3). 
PAR1b is localized to the basolateral membrane in normal polarized epithelial cells, while 
atypical protein kinase C (aPKC) complex is localized specifically to the apical membrane. 
When CagA is delivered and injected into normal polarized gastric epithelial cells, CagA 
inhibits the kinase activity of PAR1b by binding directly to its kinase domain, which 
subsequently leads to junctional and polarity defects followed by the disorganization of the 
epithelial monolayer (Sadaat et al., 2007). PAR1b exists as a homodimer in the cells, and two 
CagA protein bind to a PAR1b dimer, which is also essential for stable CagA-SHP2 
interaction. 
Recently, a cytosilic pattern recognition receptor, nucleotide-binding oligomerization 
domain protein 1 (NOD1), was found to respond to peptidoglycan delivered by H. pylori 
cagPAI (Viala et al., 2004). NOD1 is known to sense the essential gamma-D-glutamyl-meso-
diaminopimelic acid (i.E.-DAP) dipeptide, which is uniquely contained in peptidoglycan of 
all gram negative and certain gram-positive bacteria (Neel et al., 2003). 
As the precise relationship of gastric precancerous lesions like gastric atrophy (GA) and 
intestinal metaplasia (IM) with these cagPAI-associated molecules is largely left unknown, 
further investigations are required to clarify the roles of these cagPAI-related molecules in 
the genesis of gastric precancerous lesions.  
PTPN11 (Protein tyrosine phosphatase, non-receptor type, 11) 
The PTPN11 G/A polymorphism at intron 3 (rs2301756), is a G-to-A single nucleotide 
substitution at 223 bp upstream of exon 4 in the PTPN11 gene encoding SHP-2 at 
chromosome 12q24.1. The biological function of this polymorphism has not yet been 
reported. The first dataset showed that one (11.1%) out of 9 infected individuals with the AA 
genotype had gastric atrophy, while 134 (56.1%) among 239 infected with the G allele had 
atrophy (Goto et al., 2006a). Our recent report of 1,636 non-cancer Japanese subjects 
demonstrated that the risk of severe gastric atrophy was significantly reduced for those with 
at least one A allele of this PTPN11 G/A polymorphism at intron 3 (OR = 0.62, 95% CI = 
0.42-0.90), confirming the association of this PTPN11 gene polymorphism with the risk of 
gastric precancerous lesions in H. pylori-infected subjects (Hishida et al., 2009a). If the 
polymorphism is functional or linked to a functional one, the association can be biologically 
explained by the difference in the strength of signal transduction through the CagA-SHP2 
complex. According to the NCBI dbSNP, the frequencies of the G allele of rs2301756, high 
risk allele for gastric atrophy, is 0.802 among 1,484 Japanese and 0.917 among 48 Chinese, 
while the corresponding was 0.348 among 46 African American and 0.064 among 46 
Caucasians, indicating that Japanese and Chinese become high risk ethnic groups through 
CagA-positive H. pylori infection, if the hypothesis that the G allele confers stronger signals 
via the CagA-SHP2 interaction is true. 
NOD1 
Recent report revealed that the carriage of the NOD1 G796A (E266K) mutation increases the 
susceptibility for gastric atrophy strikingly: OR = 34.2 in NOD1 796AA and OR = 13.35 in 
NOD1 796GA compared to subjects with NOD1 796GG (Kara et al., 2010). 
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Fig. 3. Signal pathways induced by the Helicobacter pylori cag pathogenicity island related 
molecules. 
2.2.2 Immune related genes and their polymorphisms 
For the effects of pro-inflammatory immune response by the hosts, TLR4 is known to 
recognize lipopolysaccharide (LPS) of gram-negative bacteria and is proved to play 
important roles in H. pylori infection through the interaction of macrophage/monocyte 
TLR4 with H. pylori LPS. The initial recognition of LPS and subsequent signaling by TLR4 is 
supported by several accessory proteins: LPS first binds to lipopolysaccharide-binding 
protein (LBP) which works as an opsonin for CD14 which then acts as a catalyst for the 
binding of LPS to MD-2. The signal induced by LPS/MD-2/TLR4 complex is transmitted 
through myeloid differentiation factor 88 (MyD88), interleukin (IL)-1 receptor associated 
kinase (IRAK), tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) and 
inhibitory κB kinase (IKK) to nuclear factor (NF)- κB, leading to the production of pro-
inflammatory cytokines such as IL-1A, IL-1B, IL-6 or TNF-A. The human immune system is 
also balanced by the anti-inflammatory cytokines like IL-10, IL-4 or IL-13 which are 
controlled by regulatory T-cells. In these inflammatory processes, augmented expression of 
inducible nitric oxide synthase (iNOS) is shown to play important roles in the generation of 
oxygen radicals, while overexpressed cyclooxygenase-2 (COX-2) is demonstrated to 
contribute to the proliferation of the gastric epithelium through the up-regulation of cell-
cycles as well as to the propagation of gastric inflammation via the prostaglandin pathways. 
The induction of iNOS is also supposed to be modulated by the activity of protein kinase C-
eta (PRKCH) via the phosphorylation of nuclear factor-kappa B (NF-kB) or activator 
protein-1 (AP-1) (Pham et al., 2003a; Pham et al., 2003b). 
 Oxidative DNA damage is also supposed to play important roles in the pathogenesis of H. 
pylori-induced gastric mucosal damage, where 8-OHdG is a potential sensitive marker of 
DNA oxidation (Farinati et al., 2008). The damaged bases in DNA are mainly repaired by 
the base excision repair (BER) system; the accumulation of 8-Hydroxy-2’-deoxyguanosine 
(8-OHdG) or 2-hydroxyadenine (2-OH-A) in DNA is prevented by the co-operation of mutT 
human homolog-1 (MTH1), 8-hydroxyguanine DNA glycosylase (OGG1) and mutY human 
homolog (MUTYH) (Nakabeppu et al., 2004). The number of studies that investigated the 
contribution of these molecules involved in inflammatory response, such as innate immune 
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response, oxygen radical production, oxidative DNA damage repair processes, together 
with cell-cycle regulation and/or cell proliferation in the genesis of H. pylori-induced gastric 
precancerous lesions is also limited, requiring further biological investigations in the near 
future. 
TLR4 
One study in Caucasians showed that the TLR4 +896 A/G polymorphism (rs4986790) was 
associated with the risk of gastric atrophy, where the TLR4 +896 G carriers had an 11-fold 
increased risk of gastric atrophy with hypochlorhydria (Hold et al., 2007). Subsequent 
Japanese study also clarified the possible association between another genetic variation in 
TLR4 gene, the TLR4 +3725G/C polymorphism (rs11536889), and the risk of severe gastric 
atrophy in Japanese (Hishida et al., 2009a), suggesting the significance of genetic variations 
in host innate immunity due to TLR4 polymorphisms also in East Asian populations. 
CD14 
There is one single nucleotide polymorphism in the promoter region of the CD14 gene, 
CD14 C-159T polymorphism, which is critical for CD14 expression (Zhang et al., 1994). 
Recent study by one Japanese group demonstrated that CD14 promoter -159TT and T carrier 
were associated with lower risk of gastric atrophy in H. pylori-infected subjects who were 61 
years or older (Tahara et al., 2007). 
IL-2 and IL-13 
IL-2 T-330G polymorphism was demonstrated to be a functional polymorphism (Williams et 
al., 1988), with higher IL-2 production in GG genotype than in TT genotype (Hoffmann et al., 
2001). Those with TT genotype were shown to be at a higher risk of gastric atrophy (Togawa 
et al., 2005), who were less frequent in Asians (38% out of 29 individuals) than in Caucasians 
(51% out of 199 individuals) (Hoffmann et al., 2002). 
IL-13 gene in chromosome 5q31 has several polymorphisms; at least 3 polymorphisms at the 
promoter region, 2 polymorphisms at intron 1, Arg130Gln, and 4 polymorphisms at 3’ UTR 
of exon 4 have been reported (Howard et al., 2001). The -1111TT genotype was shown to 
harbor increased binding ability of nuclear proteins, and was also reported to be associated 
with asthma (Howard et al., 2001; Van der Pouw Kraan et al, 1999). As for the risk of gastric 
atrophy, -1111TT was found to be a low risk genotype (Togawa et al., 2005). The biological 
mechanism involved was not yet clarified. 
IL-4R 
One study of Venezuelan subjects revealed that those with homozygotes with the low 
activity allele (GG) of the A398G polymorphism in the IL-4R gene (rs1805010) had a 
modestly increased risk of gastric atrophy (OR = 1.52, 95% CI = 1.05-2.21) (Kato et al., 2006), 
suggesting the role of genetic variability in the anti-inflammatory mediators in the genesis of 
H. pylori-induced gastric precancerous lesions. 
iNOS C150T (rs2297518) and PRKCH rs3783799 G/A polymorphisms: PRKCH is shown to 
be involved in oxidative stress, by activating iNOS and nitric oxide production (Pham et al., 
2003). The associations of the polymorphisms in these two genes (iNOS C150T [rs2297518] 
and PRKCH rs3783799 G/A polymorphisms) with the risk of gastric atrophy were 
investigated in Japanese population, which revealed that those with PRKCH rs3783799 AA 
genotype were at significantly higher risk of severe gastric atrophy (OR = 2.37, 95% CI = 
1.11-5.05) (Goto et al., 2010), while there were no significant association between the iNOS 
C150T polymorphism and risk of gastric atrophy (Goto et al., 2006b). 
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2.2.3 Other miscellaneous genes and their polymorphisms 
Recently, it was reported that the loss expression of sonic hedgehog (Shh), a regulatory gene 
essential for developmental patterning, and aberrant expressions of caudal-type homeobox 
transcription factor 2 (CDX2), a master regulatory gene of intestinal development and 
differentiation, in H. pylori-induced atrophic gastritis are the early events correlated with the 
occurrence of intestinal metaplasia, which can be reversible by the eradication of H. pylori. In 
accordance with these findings, CDX2 expression has been demonstrated to be associated 
with intestinal phenotypes in gastric cancers (Shiotani et al., 2008). 
Another important tumor suppressor gene in intestinal-type gastric cancer is runt-related 
gene 3 (RUNX3) encoding a subunit of polyomavirus enhancer binding protein 2 (Li et al., 
2002), since expression of RUNX3 is greatly reduced in intestinal metaplasias in human 
stomachs (Oshio et al., 2004) and RUNX3-/- mouse gastric epithelial cells have a potential to 
differentiate into CDX-2 positive intestinal type cells (Oshio et al., 2004). Li and colleagues 
(Li et al., 2002; Levanon et al., 2003) reported that the gastric mucosa of RUNX3 null mice 
showed hyperplasia, indicating that loss of RUNX3 leads to gastric carcinogenesis in 
humans. Consistent with this, an analysis of RUNX3 in human stomach cancer cell lines and 
primary human tumours revealed hemizygosity in 40% of the tumours examined, and 
silencing by promoter hypermethylation in 60% of the tumours, and this figure increased up 
to 90% in the advanced stage tumours. It is shown that the RUNX3-/- mouse gastric mucosa 
exhibits hyperplasias due to the stimulated proliferation and suppressed apoptosis in the 
cells, suggesting that RUNX3 is an attractive candidate as a tumor suppressor of gastric 
cancer. The CpG island of RUNX3 P2 promoter is hypermethylated in human and mouse 
gastric cancer cell lines and in primary human tumors (Li et al, 2002; Waki et al., 2003), also 
suggesting the tumor suppressor function of RUNX3 in the etiology of stomach cancer. 
Heat-shock protein (HSP) 70 plays essential roles in cellular response to a variety of 
environmental stresses by acting as molecular chaperons in the folding of newly synthesized 
proteins in cells and assist in the folding of damaged proteins (Becker et al., 1994). HSP 
expression in the gastric mucosa is shown to be attenuated by H. pylori infection and aspirin 
intake, and one HSP inducer geranylgeranylacetone (GGA) reportedly protects gastric 
mucosa from iNOS induced by H. pylori infection (Yeo et al., 2004), suggesting that HSP has 
important roles in protecting gastric mucosa against H. pylori or aspirin induced injuries. 
Gastric carcinogenesis can also be regarded as a multistep process that initiates with the 
disregulation of normal controls of apoptoisis and cell proliferation, in which FAS receptor-
ligand system is shown to be a key regulator of apoptosis (Hsu et al., 2008). 
Pepsinogen C (PGC), alternatively called pepsinogen II or gastricsin, an inactive precursor 
of pepsin C, is an aspartic protease specifically produced by the gastric chief cells, cardiac 
cells, pylori cells and Brunner’s glands from late infant stages to adulthood period. PGC is 
considered to be a differentiation marker of gastric epithelium, whose changes in expression 
may reflect the severity of gastric mucosal damage (Samloff et al., 1982). 
RUNX3  
Among H. pylori seropositive subjects, we found a significant association between RUNX3 
rs760805 T/A polymorphism and the risk of gastric atrophy with the age- and sex-adjusted 
OR of 1.51 (95% CI 1.11-2.05, P=0.008) in TA, 1.59 (95% CI 1.08-2.33, P=0.019) in AA, and 1.53 
(95% CI 1.14-2.05, P=0.004) in TA+AA, compared with TT genotype (Hishida et al., 2009b). 
This finding was in accordance with the recent biological report that RUNX3 expression 
correlated with chief cell differentiation in human gastric cancers (Ogasawara et al., 2009). 
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Polymorphism Function Rs number Subjects
 (Reference)
OR and/or GA%
IL-1B  C-31T 5'UTR rs1143627 253 Japanese
(Atsuta, 2006)
CC (54%),CT (52%),TT (56%)
" 455 Jpn.Brazil. 
(Uno, 2004)
CC ,CT :0.61,TT :0.58 CC (36%), CT (31%), TT (21%)
" 1,328Venezuelan 
(Kato, 2007)
TT,CT :1.01,CC :0.91
IL-2  T-330G 5'UTR rs2069762 244 Japanese
(Togawa, 2005)
GG ,TG :1.64,TT :2.78 *GG (38%),TG (50%),TT (62%)
IL-4  C-33T 5'UTR rs2070874 249 Japanese 
(Togawa, 2005)
CC ,CT :2.47,TT :1.80 CC (38%),CT (60%),TT (53%)
IL-4  T-590C 5'UTR rs2243250 1,301 Venezuelan
(Kato, 2006)
TT ,CT :0.82,CC :0.81
IL-4R  C-3223T 5'UTR rs2057768 1,301 Venezuelan
(Kato, 2006)
CC ,CT :0.97,TT :1.01
IL-4R  A398G Non-synonimous (Ile50Val) rs1805010 1,301 Venezuelan
(Kato, 2006)
AA ,AG :1.14,GG :1.52*
IL-6  G-174C 5'UTR rs1800795 1,315 Venezuelan
(Kato, 2007)
GG ,CG :0.98,CC : 0.57
IL-8  T-251A 5'UTR rs4073 1,347 Venezuelan
(Kato, 2007)
TT ,AT :0.98,AA :1.07
IL-10  G-1082A 5'UTR rs1800896 1,301Venezuelan 
(Kato, 2006)
GG ,AG :1.05,AA :1.14
IL-13  C-1111T 5'UTR rs1800925 248 Japanese
(Togawa, 2005)
CC ,CT+TT :0.41 *CC (59%),CT+TT (45%)
TNF-A  T-1031C 5'UTR rs4647198 455 Jpn.Brazil. 
(Atsuta, 2006)
CC (29%),TC (33%),TT (34%)
               C-857T 5'UTR rs1799724 456 Jpn.Brazil.
(Atsuta, 2006)
CC (32%),CT (36%),TT (39%)
             -1031&-857 455 Jpn.Brazil.
(Atsuta, 2006)
CC&CC (29%),TT&CC (33%),TC&CT (43%),TT&TT (39%)
               G-308A 5'UTR rs1800629 1,327 Venezuelan 
(Kato, 2006)
GG,AG+AA :1.27
MCP1  G-2518A 5'UTR rs1024611 1,311 Venezuelan
(Kato, 2007)
AA ,AG :1.02, GG :1.18
PTPN11  G/A at intron3 intron rs2301756 248 Japanese 
(Goto, 2006a)
GG ,GA :0.70,AA :0.09 *GG (59%),GA (49%),AA (11%)
" 979 Japanese 
(Hishida, 2009a)
GG ,GA+AA :0.62
‡ 
*GG (22%),GA+AA (15%)
‡
NOD1  G796A Non-synonimous (Glu266Lys) rs2075820 150 Turks
(Kara, 2010)
GG ,GA : 13.35*,AA :34.2*
TLR4  A+896G Non-synonimous (Asp299Gly) rs4986790 103 Caucasians
(Hold, 2007)
AA ,AG :11.0* AA (36%),AG (87%)
§
" 717 Venezuelan 
(Kato, 2007)
GlyGly/ AspGly,AspAsp : 1.53
TLR4  G+3725C 3'UTR rs11536889 980 Japanese
(Hishida, 2009b)
GG,GC+CC:1.33 GG(18%),GC+CC(22%)‡
CD14  C-159T(C-260T) 5'UTR rs2569190 717 Venezuelan
(Kato, 2007)
CC,CT+TT :1.06
PRKCH  rs3783799 G/A intron rs3783799 1,638 Japanese
(Goto, 2010)
GG ,GA :0.99,AA :2.37*
iNOS  C150T Non-synonimous (Ser608Leu) rs2297518 250 Japanese
(Goto, 2006a)
CC ,CT+TT :0.75
RUNX3  T/A at intron3 intron rs760805 938 Japanese
(Hishida, 2009)
TT ,TA :1.51*,AA :1.59*TT (46%),TA (56%),AA (56%)
HSP70-2  A/B (A1267G) Synonimous (Gln351Gln) rs1061581 137 Japanese
(Tahara, 2009)
BB (45%),AA+AB (67%)
‡
FAS  G-1377A 5'UTR rs2234767 109 Taiwanese
(Hsu, 2008)
No association
FAS  A-670G 5'UTR rs1800682 109 Taiwanese
(Hsu, 2008)
No association
FASL  T-844C 5'UTR rs763110 109 Taiwanese
(Hsu, 2008)
TT ,TC+CC :9.4*
PGC  Ins/Del Ins/Del (unknown) 86 Chinese
(Pham, 2003)
DD (90%),others(50%)*
NQO1  C609T Non-synonimous (Pro187Ser) rs1800682 396 Japanese
(Goto, 2005a)
TT ,CT :1.25,CC :1.23
GSTM1 Ins/Del (unknown) 396 Japanese
(Goto, 2005a)
Null ,Present :1.35
GSTT1 Ins/Del rs71748309 396 Japanese
(Goto, 2005a)
Null ,Present :0.87
ACE  Ins/Del Ins/Del rs1799752 271 Japanese 
(Goto, 2005c)
II ,ID :1.12,DD :0.99
RANTES  C-471T 5'UTR rs2107538 344 Germans 
(Hellmig, 2005)
No association
SDHC  JST173800 C/G 3'UTR rs3813632 249 Japanese
(Goto, 2006c)
CC ,GC :1.26,GG :0.51 CC (53%), GC (59%), GG (38%)
IFNGR1  G-611A 5'UTR rs1327474 805 Portugese 
(Canedo, 2008)
GG ,GA :1.2,AA :1.2
IFNGR1 C-56T 5'UTR rs2234711 814 Portugese 
(Canedo, 2008)
CC ,CT :1.4,TT :1.3
 
Table 4. Polymorphisms associated with gastric atrophy Helicobacter pylori seropositives. 
Polymorphisms of other miscellaneous genes 
HSP 70-2 
It is shown that the AA genotype of HSP 70-2 A/B polymorphism (PsiI polymorphism, 
corresponding to A1267G polymorphism) had the highest level of mRNA expression 
compared with the other genotypes (AB or BB). Recently one Japanese group reported that 
the BB genotype of HSP 70-2 gene is significantly associated with the reduced risk of severe 
gastric atrophy in H. pylori infected older subjects (Tahara et al., 2009), indicating the 
importance of this HSP polymorphism in the genesis of H. pylori-induced gastric 
precancerous lesions. 
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FASL 
Lately one study group in Taiwan investigated the relations between precancerous gastric 
lesions and polymorphisms in the promoter regions of the death pathway genes FAS and 
FASL (FAS G-1377A, FAS A-670G and FASL T-844C) in 109 H. pylori-infected Taiwanese 
individuals, and found that FASL -844 C allele significantly increased the risk of atrophy in 
the gastric corpus, with an adjusted OR of 5.0 (95% CI = 1.5-6.8) (Hsu et al., 2008). 
PGC 
Recent study among Chinese demonstrated that subjects with PGC Del/Del genotype of the 
PGC ins/del polymorphism were at significantly higher risk of atrophic gastritis (OR=3.11; 
95%CI 1.44-6.71), and H. pylori-seropositive subjects with PGC Del/Del genotype had 
significantly elevated risk of atrophic gastritis (OR=11.16; 95%CI 1.37-90.84) with the 
interaction of 6.48 (Sun et al., 2009), suggesting the positive link between PGC gene 
polymorphism and H. pylori-induced gastric atrophy. 
2.3 Genetic factors for Helicobacter pylori-induced gastric carcinogenesis 
To date, many genetic polymorphisms have been examined on the associations with gastric 
cancer in case-control studies with the mixed cases (H. pylori-related and H. pylori-unrelated) 
and controls at different stages (unexposed to H. pylori, exposed but uninfected, infected but 
without gastric atrophy, and with gastric atrophy), as shown in Fig. 5. Since those case-
control studies compared genotype frequencies between the mixed cases and heterogeneous 
controls, the estimated odds ratios did not reflect any distinct step to gastric cancer. Controls 
unexposed to H. pylori have the same genotype frequency as the average among the 
exposed, which reduces the difference in the genotype frequency between the uninfected 
and infected. In order to measure the associations between genotypes and H. pylori infection, 
the studies are to be conducted at a region where the exposure to the bacterium was highly 
prevalent. Usual case-control studies could provide the estimates for the final step (ie, literal 
carcinogenesis), when genotype frequency is different between gastric atrophy and gastric 
cancer, and the same among the uninfected, infected, and those with gastric atrophy. 
Table 5 lists the polymorphisms reported on gastric cancer risk, adopted from Gonzalez et 
al.(Gonzalez et al., 2002) and recent studies(Ebert et al., 2005; Geddert et al., 2005; Li et al., 
2005; Tsukino et al., 2002; Sugimoto et al., 2005; Gao et al., 2002; Wu et al., 2002; Goto et al., 
2005; Lai et al., 2005a; Lee et al., 2004; Savage et al., 2004; Lai et al., 2005b; Lacasana-Navarro 
et al., 2006; Kim et al., 2005; Hamajima et al., 2002a; Duarte et al., 2005). The ORs are listed in 
case of being significant. Accordingly, it should be noted that there were many insignificant 
studies behind Table 5. 
There are several studies to demonstrate the risks of both gastric atrophy and gastric cancer 
in comparison with the same controls without gastric atrophy. Individuals with IL-8 -251A 
allele had OR=1.50 with 95% confidence interval (95%CI)=0.98-2.23 for gastric atrophy and 
OR=1.50 with 95%CI=1.00-2.25, indicating that the risk elevation was due to the risk for 
gastric atrophy, not for the step from gastric atrophy to gastric cancer.(Taguchi et al., 2005) 
The direct comparisons between controls with gastric atrophy and cases with gastric cancer 
were reported; no associations for p53 Arg72Pro (Hiyama et al., 2002; Chung et al., 2006), 
and for PTPN11 G/A at intron 3 (Goto et al., 2006a). 
Lifestyle factors may interact with the genotypes in the final step. Biologically, the 
interactions of smoking, fresh vegetables/fruits and salty food with polymorphisms of 
carcinogen-metabolic enzyme and DNA repair enzymes are very plausible. 
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Polymorphism                    Country(Reference)                                                   OR (95%CI) 
ACE I/D                             Germany (Ebert, 2005)                                              DD, DI:0.55 (0.31-0.96),  
 II:0.20 (0.08-0.54) 
cyclinD1 G870A                       Germany(Geddert, 2005)                                                                        significant association (p=0.003) 
CYP1A1 Ile/Val                       China(Li, 2005) IleIle, ValVal:4.84 (1.24-22.07) 
CYP2C6 *1/*4                         Japan(Tsukino, 2002) *1*1/*1*4, *4*4:3.14 (1.05-9.41) 
CYP2C19 *1/*2/*3                     Japan(Sugimoto, 2005)                                                                         * 1*1, no*1:1.98 (1.07-3.65) 
CYP2E1 RsaI                          Japan*                                               
Brazil*  
China(Gao, 2002) 
E-cadherin C-160A                  Taiwan(Wu, 2002) CC, AA:0.20 (0.06-0.56) 
EGF A61G                           Japan(Goto, 2005)   
GSTM1present/null                        UK*                                  present, null:2.9 (1.25-6.73) 
 Japan* present, null:1.70 (1.05-2.8) 
 Iran* present, null:2.3 (1.15-4.95) 
Poland* 
China(Li, 2005)         present, null:2.81 (1.39-5.71) 
Taiwan(Lai, 2005) present, null:1.75 (1.04-2.96) 
GSTM3 IVS6del3                      Poland* 
GSTP1 I105V                          Japan* 
Poland* 
GSTT1 present/null               China*                        present, null:2.5 (1.01-6.2) 
 Poland*     present, null:3.1 (1.5-6.5)  
      among current smokers 
 Japan* 
IL-1B C-1473G      Korea (Lai, 2005) 
C-511T                         Poland(El-Omar, 2000)        CC, CT:1.8 (1.3-2.4), 
      TT:2.6 (1.7-3.9) 
 Portugal*     CC, CT/TT:1.7 (1.1-2.7) 
 Taiwan(Wu, 2003) 
      C3954T                        Poland(El-Omar, 2000) 
IL-1RN 86-bp VNTR                     Poland(El-Omar, 2000)          4rpt4rpt, 2rp2rp:3.7 (2.4-5.7) 
Taiwan(Wu, 2003) 
IL-1B C-511T+      Portugal*     CC+LL/L2rpt,  
IL-1RN 86-bp VNTR                       CT/TT+2rpt2rp:9.0 (3.5-23.0) 
IL-2 G-384T, G114T   China(Savage, 2004) 
IL-4 C-590T                           Taiwan(Wu, 2003; Lai, 2005) 
RP1/RP2                        Taiwan(Lai, 2005) 
IL-4R Ile50Val                         Taiwan(Wu, 2003) 
     Gln576Arg                       Taiwan(Wu, 2003) 
IL-10 G-1082A                         Taiwan(Wu, 2003)  AA, AG:2.14 (1.07-4.30) 
China(Savage, 2004)  
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T-819C                         Taiwan(Wu, 2003)  TT, TC:1.83 (1.23-2.71), 
                                                   CC:1.95 (1.03-3.69) 
 China(Savage, 2004) 
MK G-2669A                         Taiwan(Lai, 2005) 
MTHFR C677T        China*     CC, TT:1.87 (1.00-3.48) 
 Mexico(Lacasana-Navarro, 2006)      CC, TT:1.62 (1.00-2.59) 
C677T, A1298C   Korea(Kim, 2005) 
MUC1 VNTR                         Portugal*     Large, Small: 4.3 (1.8-10.5) 
MUC6 VNTR        Portugal*     Large, Small: p<0.05 
MYCL1 EcoRI        Japan*     LL, LS:1.55 (1.03-2.34) 
 Japan*     LL, LS/SS:3.09 (1.33-7.21)  
NAT1               UK*     slow, rapid:2.6 (1.3-5.3) 
 Japan* 
NAT2               UK* 
 Japan* 
NQO1 C609T        Japan(Hamajima, 2002d) 
OGG1 Ser327Cys     Japan* 
 Brazil* 
p16INK4A C540G            Germany(Geddert, 2005)  
C570G       Taiwan(Lai, 2005) 
p21 codon31          Taiwan(Lai, 2005) 
p53 codon72                         Taiwan(Lai, 2005)       significant association (p=0.02) 
PPAR┛ Pro12Ala(C/G)                    China(Liao, 2006)       CC, CG/GG:2.5 (1.1-5.8) 
TFF2 VNTR           Portugal*  
TNF-A G-308A         Korea* 
 Taiwan(Wu, 2003) 
       G-238A        Korea*  
 Taiwan(Wu, 2003) 
XRCC1 Arg194Trp    Brazil(Duarte, 2005)  
       Arg399Gln       Brazil(Duarte, 2005) 
Arg194Trp+   China*     TrpTrp+ArgArg, ArgArg+ 
Arg399Gln      ArgGln/GlnGln:1.73 (1.12-2.69) 
XRCC3 Thr241Met    Brazil(Duarte, 2005) 
 
* Studies cited in the review by Gonzalez et al. (2002).  
L: alleles longer than 2rpt   
Table 5. Polymorphisms reported on the associations with gastric risk> only singnificant are 
with odds ratio (OR) and 95% confidence interval (95%CI). 
3. Conclusion 
It is clear that H. pylori-related gastric cancer develops through several steps including the 
infection, gastric atrophy, (histologically intestinal metaplasia, dysplasia) and cancer. 
Lifestyle factors such as smoking and diet could influence one or more steps. On the other 
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hand, genotypes may be step-specific because the biological process is distinct in the 
different steps. Accumulated findings on the associations between gastric cancer risk and 
polymorphism genotypes demonstrated that the strength of associations varied among the 
studies. Since usual case-control studies examined the mixed effects on these steps, the 
inconsistent findings may be natural. In addition, the diversity of lifestyle interacting with 
the genotypes among the different study subjects may enlarge the inconsistency. In order to 
elucidate the genetic traits of H. pylori-related gastric cancer, the studies on each step taking 
into account of the lifestyle factors will be requested. Such studies will produce useful 
information for gastric cancer prevention. 
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